| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1041616G |
| P356 | DOI | 10.1371/JOURNAL.PONE.0141616 |
| P932 | PMC publication ID | 4624805 |
| P698 | PubMed publication ID | 26509687 |
| P5875 | ResearchGate publication ID | 283306030 |
| P2093 | author name string | Xin Lu | |
| Guochun Wang | |||
| Xiaoming Shu | |||
| Qinglin Peng | |||
| Yongpeng Ge | |||
| P2860 | cites work | RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease | Q33476226 |
| Polymyositis and dermatomyositis (second of two parts) | Q33909233 | ||
| Polymyositis and dermatomyositis (first of two parts) | Q33911013 | ||
| Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies | Q34074602 | ||
| A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy | Q34520109 | ||
| Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies | Q35151003 | ||
| Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin | Q35163067 | ||
| Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy | Q35284449 | ||
| Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy | Q35909737 | ||
| Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan | Q36153401 | ||
| Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. | Q36434543 | ||
| Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies. | Q37691061 | ||
| Myositis autoantibodies | Q38041385 | ||
| Autoantibodies in polymyositis and dermatomyositis | Q38099556 | ||
| Reliability and validity of the myositis disease activity assessment tool | Q57752642 | ||
| 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands | Q57752724 | ||
| Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins | Q85072206 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | idiopathic inflammatory myopathy | Q55789135 |
| P304 | page(s) | e0141616 | |
| P577 | publication date | 2015-10-28 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies | |
| P478 | volume | 10 |
| Q33584194 | A Case of Statin-Associated Autoimmune Myopathy |
| Q88315057 | Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure |
| Q45969468 | Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients. |
| Q39030495 | Autoimmune Myopathies |
| Q37324573 | Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy |
| Q51527887 | Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. |
| Q38851108 | Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease |
| Q64319482 | Coexistence of anti-HMGCR and anti-MDA5 identified by an unlabeled immunoprecipitation assay in a chinese patient cohort with myositis |
| Q52628910 | Immune-Mediated Necrotizing Myopathy. |
| Q50948932 | More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. |
| Q33620443 | Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies. |
| Q64885943 | Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed. |
| Q96305510 | Statin-Induced Immune-Mediated Necrotizing Myopathy: An Increasingly Recognized Inflammatory Myopathy |
| Q52688656 | Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations. |
| Q88062936 | The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy |
Search more.